McGraw-Hill is proud to introduce Hot Topics as a new service to AccessPharmacy subscribers. A Hot Topic is an editorial review of a recent clinical trial or systematic review. Read more about Hot Topics.

McGraw-Hill is proud to introduce Hot Topics as a new service to AccessPharmacy subscribers. A Hot Topic is an editorial review of a recent clinical trial or systematic review. These editorials are written by academic clinicians. The Hot Topic is not just a synopsis of the article but rather a critical appraisal placed into context with what is already known about the subject.

Currently over 2,000,000 articles are published each year and that number doubles every 6 to 7 years. It is impossible for busy clinicians to keep current with this information overload. The editors and contributing authors of AccessPharmacy’s Hot Topics systematically review the contents of the major medical and pharmacy journals. When landmark trials are published, these authors will carefully review the results so the reader will understand whether this new information is relevant to clinical practice.

McGraw-Hill has carefully chosen the editors and contributing authors to reflect the numerous clinical specialties in pharmacy. Their years of clinical practice along with their training in evidence-based medicine ensure the high quality of the Hot Topics. We believe that you will value the insights provided by Hot Topics whether you are an academician, a clinician, or both.

Hide